Billionaires Just Sold Shares of AI Giant: What It Means
Quarterly filings reveal big-money moves. Seven of eight ultra-rich fund managers trimmed a single AI stock that’s su...
Choosing between methods depends on goals; zero based budgeting offers precise allocations, while traditional budgeting provides familiarity and simplicity.
25,168 articlesQuarterly filings reveal big-money moves. Seven of eight ultra-rich fund managers trimmed a single AI stock that’s su...
CRISPR Therapeutics stock has zigzagged all year, driven by pipeline milestones, regulatory updates, and funding need...
Insider moves can mislead, but context matters. This article explains why Nick Khan’s 9,589 share sale isn’t a warnin...
Airgain's 2025 earnings outlook hinges on product mix, OEM momentum, and margin discipline. This guide breaks down th...
A Tuesday uptick in Edgewise Therapeutics stock topped the market, driven by an upbeat price target from a major bank...
A large fund snapped up 1.2 million Vir Biotechnology shares as the stock doubled this past year. Here’s how to read ...
A large institutional bet on Futu stock sparked headlines as shares fell nearly a quarter. This article breaks down w...
Investors weigh Pfizer's CFO transition as the broader market climbs. This look at the stock market today, june revea...
As quantum dreams grow from labs to law and logistics, Rigetti's domestic footprint and government ties could propel ...
Paradigm is preparing a $1.5B fund to invest in AI, robotics, and frontier technologies while maintaining crypto inve...
Pi Network announces the completion of a groundbreaking upgrade to protocol 20.2. While the upgrade lays the groundwo...
Maze Therapeutics stock still faces mixed signals from the market: a strong rally after a March dip, paired with a no...